Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Iron Contributes to Plaques in Alzheimer's Disease

By LabMedica International staff writers
Posted on 26 Oct 2010
There is a very close link between elevated levels of iron in the brain and the enhanced production of the amyloid precursor protein (APP) in Alzheimer's disease.

This protein (APP) breaks down into a peptide that makes up the destructive amyloid plaques that are characteristic of Alzheimer's disease (AD). More...
An abundance of iron in brain cells results in an abundance of APP, and its destructive peptide residue.

In a study, carried out at Massachusetts General Hospital, (Boston, MA, USA), scientists were able to identify important molecules in the system of checks and balances used to regulate iron in brain cells. Iron-regulating protein 1 (IRP1), is the special molecule that attaches to the messenger ribonucleic acid (mRNA) that is key to the production of APP. The team had previously reported that, if there is too little iron, fewer APP molecules are made available to help escort iron out. As a result, iron accumulates, and the process begins again in a feedback loop. When there is less iron in the brain cell, IRP1 is more likely to link up with the RNA, which prevents the production of APP. When there is abundant iron present, IRP1 does not connect to the RNA, and APP production becomes excessive.

The finding that steady-state levels of intracellular APP are tightly regulated by iron is consistent with the preliminary clinical studies showing that copper and iron chelation may therapeutically reduce APP levels and lower Aβ peptide product in brain subregions. Inhibition of APP translation mediated through the APP 5′-untranslated region (UTR) provides another mechanism by which chelators could be therapeutic agents for the treatment of AD patients

Jack T. Rogers, Ph.D., the senior author, said, "these findings lay the foundation for the development of new therapies that will slow or stop the negative effects of iron buildup in patients with the progressive neurodegenerative disease, symptoms of which include memory loss, impaired judgment, and disorientation and personality changes." The study was published on October 2010, in the Journal of Biochemistry.

Related Links:

Massachusetts General Hospital


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.